A key aspect to routine microbiology processes include the retrieval, transport and 27 maintenance of specimens. Swab transport systems (STS) can be utilised for their low 28 cost, ease of use and their ability to recover and maintain specimens over long 29
INTRODUCTION 51
There has been a global increase of infections caused by invasive fungi, with molds 52 and yeasts repeatedly described as pathogens (1). Of these infections, it is indicated 53 that Candida spp. are a leading cause, and candidiasis effects more than a quarter of 54 a million patients worldwide every year (2). This increase in opportunistic fungal 55 pathogens can be linked to the progression of medical actions such as chemotherapy 56 and transplants which results in an increase in immuno-compromised patients (3). 57
One species of Candida that is of particular concern is C. auris. Since the discovery 58 of C. auris in 2009 (4) there have been rising concerns due to its rapid spread across 59 the globe in the short time since its discovery (5); common misidentification for other 60
Candida spp. (6-9); the serious associated infections including reports of isolation 61 from the bloodstream, urinary tract, ear canal, wounds, heart muscle and bone (10); 62 high mortality rate (10-12); and it's antifungal resistance (6, 13). Rapid and efficient 63 isolation and identification of these infectious agents are paramount to successful 64 treatment, thus swab transport systems (STS) are often used for their low cost, ease 65 of use and ability to maintain microorganism viability over extended periods of time 66 (14). The Clinical and Laboratory Standards Institute (CLSI) M40-A2 is an approved 67 standard which outlines testing procedures for liquid transport systems and provides 68 manufacturers and end-users with a criteria for compliance (15). This protocol 69
indicates the methodology to be used, storage conditions and length of incubation time 70
for testing various STS. The protocol also outlines a list of organisms to be used for 71 quality control, though amongst these organisms, yeasts are only indicated for urine 72 transport systems. The compliance criteria of an STS in M40-A2 is described as no 73 greater than 3 log decrease when stored at 4 °C or room temperature, or 1 log increase 74 when stored at 4 °C. The enumeration should also be ≥5 CFU from the same dilution 75 4 as used in time-zero plate counts after the specified holding period. The aim of this 76 study is to investigate and evaluate the efficiency of two commercial transport swabs 77 to recover several Candida spp., including C. auris, using the qualitative roll-plate 78 method outlined by the M40-A2. 79
80

METHODS 81
The method in this study followed the CLSI M40-A2 protocol with some minor 82 adaptations. The STS used in this study were both manufactured by Medical To our knowledge, this study is the first to evaluate STS efficiency and recovery of C. 118 auris using the M40-A2 protocol. The M40-A2 does not currently directly address the 119 recovery of yeasts, with the exception of guidance for urine transport systems (15). 120
In this study it was found that when using the protocol for adjusting initial inocula, 121 enumeration was lower than that of bacteria, as expected, due to the difference in 122 size of yeast and bacterial cells. Of the Candida spp. used within this study, only C. 
